Case Report
A case report of primary squamous cell carcinoma of the breast
Translational Breast Cancer Research
2021;
2:
16
(30 April 2021)
Case Report
T-DM1 for advanced breast cancer after multi-anti-HER2-target therapy: a case report
Translational Breast Cancer Research
2021;
2:
15
(30 April 2021)
Case Report
Benefit with re-challenge of immune checkpoint inhibitors in patient with metastatic triple-negative breast cancer: a case report
Translational Breast Cancer Research
2021;
2:
14
(30 April 2021)
Review Article
Cyclin-dependent kinase 4 and 6 inhibitors at the crossroads: the combinational therapeutic strategies in breast cancer—a narrative review
Translational Breast Cancer Research
2021;
2:
13
(30 April 2021)
Review Article
Potential biomarkers of resistance to CDK4/6 inhibitors: a narrative review of preclinical and clinical studies
Translational Breast Cancer Research
2021;
2:
12
(30 April 2021)
Original Article
The role of FOXP3 of interstitial tissue in the pathogenesis of breast cancer
Translational Breast Cancer Research
2021;
2:
11
(30 April 2021)
Editorial
How bone metastases can influence the management of breast cancer
Translational Breast Cancer Research
2021;
2:
10
(30 April 2021)
Editorial
Implementing clinical practice guidelines for breast cancer management: searching for homogeneity in real-life heterogeneity
Translational Breast Cancer Research
2021;
2:
9
(30 April 2021)
Case Report
Aggressive breast fibromatosis with axillary accessory breast mastitis mimicking carcinoma: a case report
Translational Breast Cancer Research
2021;
2:
8
(31 January 2021)
Review Article
Bone metabolism and the development of denosumab: a narrative review
Translational Breast Cancer Research
2021;
2:
7
(31 January 2021)
Review Article
The evolution and advances of biomarker use in clinical trials for breast cancer treatment—a narrative review
Translational Breast Cancer Research
2021;
2:
6
(31 January 2021)
Review Article
Reprogramming of fatty acid metabolism in breast cancer: a narrative review
Translational Breast Cancer Research
2021;
2:
5
(31 January 2021)
Original Article
Occurrence and distribution of bone metastases in 984 metastatic breast cancer patients
Translational Breast Cancer Research
2021;
2:
4
(31 January 2021)
Original Article
Prognosis prediction model for patients with breast cancer with bone metastasis: based on a population database
Translational Breast Cancer Research
2021;
2:
3
(31 January 2021)
Guideline
Chinese expert consensus statement on the clinical diagnosis and treatment of breast cancer bone metastasis and bone related disease
Translational Breast Cancer Research
2021;
2:
2
(31 January 2021)
Editorial
Expanding therapeutic frontiers in metastatic HER2-positive breast cancer
Translational Breast Cancer Research
2021;
2:
1
(31 January 2021)
Original Article
Markers of steroid receptor, kinase signalling pathways and Ki-67 expression in relation to tamoxifen sensitivity and resistance
Translational Breast Cancer Research
2020;
1:
29
(31 October 2020)
Original Article
Multidisciplinary treatment of breast cancer under COVID-19 pandemic
Translational Breast Cancer Research
2020;
1:
28
(31 October 2020)
Guideline
Guidelines of Chinese Society of Clinical Oncology (CSCO) on Diagnosis and Treatment of Breast Cancer (2020 version)
Translational Breast Cancer Research
2020;
1:
27
(31 October 2020)
Editorial
Treating breast cancer patients in China
Translational Breast Cancer Research
2020;
1:
26
(31 October 2020)
Editorial
2020 Chinese Society of Clinical Oncology Breast Cancer guideline updates
Translational Breast Cancer Research
2020;
1:
25
(31 October 2020)
Editorial
Guidelines of Chinese Society of Clinical Oncology (CSCO) on Diagnosis and Treatment of Breast Cancer: an appraisal
Translational Breast Cancer Research
2020;
1:
24
(31 October 2020)
Editorial
Developing breast cancer guidelines: keep cherishing our former knowledge as we continue to acquire new
Translational Breast Cancer Research
2020;
1:
23
(31 October 2020)
Editorial
Breast cancer diagnosis and treatment: Asian perspective
Translational Breast Cancer Research
2020;
1:
22
(31 October 2020)
Editorial Commentary
Real-world study: from real-world data to real-world evidence
Translational Breast Cancer Research
2020;
1:
21
(30 July 2020)